Mechanochemical Synthesis, Spectroscopic Characterization and Molecular Structure of Piperidine–Phenytoin Salt

References (40)

1. 1 Qiu, Y., Zhang, G.G.Z., Mantri, R.V., Chen, Y., and Yu, L. (2017). API solid-form screening and selection. Developing Solid Oral Dosage Forms, Academic Press. [2nd ed.].
2. 2 Qiu, Y., Zhang, G.G.Z., Mantri, R.V., Chen, Y., and Yu, L. (2017). Solubility of pharmaceutical solids. Developing Solid Oral Dosage Forms, Academic Press. [2nd ed.].
3. 3 Wiedmann, 2016, Pharmaceutical salts: Theory, use in solid dosage forms and in situ preparation in an aerosol
4. 4 Mithu, 2021, Advanced Methodologies for Pharmaceutical Salt Synthesis [DOI]
5. 5 2012, Acid–base crystalline complexes and the pKa rule [DOI]
6. 6 Fini, 2012, Diclofenac salts, part 7: Are the pharmaceutical salts with aliphatic amines stable? [DOI]
7. 7 Pratt, 2011, Sulfapyridine (polymorph III), sulfapyridine dioxane solvate, sulfapyridine tetrahydrofuran solvate and sulfapyridine piperidine solvate, all at 173 K
8. 8 2023, Crystal structure and characterization of the sulfamethazine–piperidine salt [DOI]
9. 9 Ramanujan, 2025, Solid-State Diversity of Fenofibric Acid: Synthon Polymorphs and Salts with Altered Solubility and Dissolution [DOI]
10. 10 Bartollino, 2018, The retinoprotective role of phenytoin [DOI]
11. 11 Dean, 2009, Exploring an Anti-Crystal Engineering Approach to the Preparation of Pharmaceutically Active Ionic Liquids [DOI]
12. 12 Chiang, 2013, Incorporation of physiologically based pharmacokinetic modeling in the evaluation of solubility requirements for the salt selection process: A case study using phenytoin [DOI]
13. 13 Nokhodchi, 2003, Crystal modification of phenytoin using different solvents and crystallization conditions [DOI]
14. 14 Agrawal, 2021, Synthesis and Formulation Development of Phenytoin by Inclusion Complexation [DOI]
15. 15 Khajir, 2019, Effects of N-methylpyrrolidone and temperature on phenytoin solubility [DOI]
16. 16 Widanapathirana, 2015, Dissolution and solubility enhancement of the highly lipophilic drug phenytoin via interaction with poly (N-isopropylacrylamide-co-vinylpyrrolidone) excipients [DOI]
17. 17 Hasa, 2013, Drug salt formation via mechanochemistry: The case study of vincamine [DOI]
18. 18 Solares-Briones, M., Coyote-Dotor, G., Páez-Franco, J.C., Zermeño-Ortega, M.R., De la O-Contreras, M., Canseco-González, D., Avila-Sorrosa, A., Morales-Morales, D., and Germán-Acacio, J.M. (2021). Mechanochemistry: A Green Approach in the Preparation of Pharmaceutical Cocrystals. Pharmaceutics, 13. [DOI]
19. 19 (Mnova Structure Elucidation, 2021). Mnova Structure Elucidation, version 14.2.0-26256.
20. 20 (CrysAlisPro, 2013). CrysAlisPro, version 1.171.36.32.
21. 21 Clark, 1995, The analytical calculation of absorption in multifaceted crystals [DOI]
22. 22 Sheldrick, 2015, SHELXT—Integrated space-group and crystal-structure determination
23. 23 Sheldrick, 2015, Crystal structure refinement with SHELXL
24. 24 Farrugia, 2012, WinGX and ORTEP forWindows: An update [DOI]
25. 25 Macrae, 2006, Mercury: Visualization and analysis of crystal structures [DOI]
26. 26 Luna, O.F., Gomez, J., Cárdenas, C., Albericio, F., Marshall, S.H., and Guzmán, F. (2016). Deprotection reagents in Fmoc solid phase peptide synthesis: Moving away from piperidine?. Molecules, 21. [DOI]
27. 27 Nation, 1990, Pharmacokinetic drug interactions with phenytoin (Part I) [DOI]
28. 28 Dharani, 2018, Quantitative estimation of phenytoin sodium disproportionation in the formulations using vibration spectroscopies and multivariate methodologies [DOI]
29. 29 Jiang, 2008, NMR and FT-IR analysis of new molecular complex 1-piperidine-carboxylate-piperidinium-H2O [DOI]
30. 30 Kadam, 2011, Application of Green Chemistry Principle in Synthesis of Phenytoin and Its Biogical Evaluation as Anticonvulsant Agents [DOI]
31. 31 Max, 2004, Infrared Spectroscopy of Aqueous Carboxylic Acids: Comparison between Different Acids and Their Salts [DOI]
32. 32 Childs, 2007, The Salt-Cocrystal Continuum: The Influence of Crystal Structure on Ionization State [DOI]
33. 33 Komasa, 2015, Structural and spectroscopic properties of piperidinium-4-carboxylic acid hydrogen squarate [DOI]
34. 34 Luchian, 2015, Molecular structure of phenytoin: NMR, UV-Vis and quantum chemical calculations [DOI]
35. 35 Botros, 2013, Synthesis and anticonvulsant activity of new phenytoin derivatives [DOI]
36. 36 Guerrab, 2022, Design, synthesis, structural and molecular characterization, toxicity, psychotropic activity and molecular docking evaluation of a novel phenytoin derivative: 3-decyl-5, 5-diphenylimidazolidine-2, 4-dione [DOI]
37. 37 Akkurt, 2020, Synthesis and liquid crystalline properties of new triazine-based π-conjugated macromolecules with chiral side groups [DOI]
38. 38 Uno, 1980, Structure of 5,5-diphenylhydantoin–1-(4-bromophenyl)-4-dimethylamino-2,3-dimethylpyrazolin-5-one (1:1) [DOI]
39. 39 Camerman, 1983, Molecular structure of acetylacetone. A crystallographic determination [DOI]
40. 40 Shah, 2019, A threefold superstructure of the anti-epileptic drug phenytoin sodium as a mixed methanol solvate hydrate [DOI]

Cited by 2

Showing 1 of 2 known citations — external sources report more than can currently be individually listed.

Related research

• A Novel Catalytic Synthesis of Flavones under Autoclave Conditions and Comparative Study of Anti-cancer Activity — shares topic coverage
• Thermostability and in-vitro Antibacterial Activity of Aqueous Extracts of Tetrapleura tetraptera Pods on Multidrug Resistant Clinical Isolates — shares topic coverage
• Acute Toxicity, Phytochemistry and Anti-diarrheal Effects of Celtis integrifolia Lam. Aqueous Leaf Extract in Wistar Albino Rats — shares topic coverage
• Understanding the Reactivity of Trimethylsilyldiazoalkanes Participating in [3+2] Cycloaddition Reactions towards Diethylfumarate with a Molecular Electron Density Theory Perspective — shares topic coverage
• Understanding the Origin of the Regioselectivity in Non-Polar [3+2] Cycloaddition Reactions through the Molecular Electron Density Theory — shares topic coverage